About Nostics
Nostics is a company based in Amsterdam (Netherlands) founded in 2020 by Rochelle Niemeijer, Johan Pieter Verwey, and Eva Rennen. Nostics offers products and services including Diagnostic Platform and Pathogen Identification Tool. Nostics operates in a competitive market with competitors including Curative, Pictor, Proof Diagnostics, Aptitude Medical and Biolidics, among others.
- Headquarter Amsterdam, Netherlands
- Founders Rochelle Niemeijer, Johan Pieter Verwey, Eva Rennen
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Nostics B.V.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$1.08 M (USD), Grant
Sep 01, 2023
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Nostics
Nostics offers a comprehensive portfolio of products and services, including Diagnostic Platform and Pathogen Identification Tool.
Uses AI and spectroscopy for rapid bacterial detection and identification.
Enables point-of-care testing to guide effective treatment decisions.
Funding Insights of Nostics
Investors in Nostics
Nostics has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked |
Investor details for Nostics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Nostics
Investment portfolio details for Nostics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Nostics
Detailed financials for Nostics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Nostics Comparisons
Peer comparison for Nostics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Nostics
Nostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Curative, Pictor, Proof Diagnostics, Aptitude Medical and Biolidics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Curative is recognized for providing affordable employer-sponsored health insurance.
|
|
| Locked | Locked | Locked |
Immunodiagnostic products are developed via multiplexed assays.
|
|
| Locked | Locked | Locked |
CRISPR-based COVID-19 molecular testing devices are manufactured.
|
|
| Locked | Locked | Locked |
Provider of at-home COVID and COVID/Flu tests
|
|
| Locked | Locked | Locked |
Cell enrichment systems are provided for cancer diagnosis and treatment.
|
Detailed competitors of Nostics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Nostics
Complete news archive for Nostics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nostics
Nostics was founded in 2020 and raised its 1st funding round 3 years after it was founded.
Nostics is headquartered in Amsterdam, Netherlands.
Nostics was founded in 2020 in Amsterdam, Netherlands, to offer COVID-19 testing services within the healthcare sector. Diagnostic operations are centered on public health support through reliable testing protocols. Services are managed from the Netherlands, with co-founders Rochelle Niemeijer, Johan Pieter Verwey, and Eva Rennen leading the initiative. The company focuses on efficient testing delivery amid pandemic needs.
Nostics offers Diagnostic Platform and Pathogen Identification Tool.
Nostics has 1 investor. Key investors include European Union.